The role and regulators of extracellular vesicle (EV) secretion in hepatic ischemia/reperfusion (IR) injury have not been defined. Rab27a is a guanosine triphosphatase known to control EV release. Interferon regulatory factor 1 (IRF-1) is a transcription factor that plays an important role in liver IR and regulates certain guanosine triphosphatases. However, the relationships among IRF-1, Rab27a, and EV secretion are largely unknown. Here, we show induction of IRF-1 and Rab27a both in vitro in hypoxic hepatocytes and in vivo in warm IR and orthotopic liver transplantation livers. Interferon c stimulation, IRF-1 transduction, or IR promoted Rab27a expression and EV secretion. Meanwhile, silencing of IRF-1 decreased Rab27a expression and EV secretion. Rab27a silencing decreased EV secretion and liver IR injury. Ten putative IRF-1 binding motifs in the 1,692-bp Rab27a promoter region were identified. Chromatin immunoprecipitation and electrophoretic mobility shift assay verified five functional IRF-1 binding motifs, which were confirmed by a Rab27a promoter luciferase assay. IR-induced EVs contained higher oxidized phospholipids (OxPL). OxPLs on the EV surface activated neutrophils through the toll-like receptor 4 pathway. OxPL-neutralizing E06 antibody blocked the effect of EVs and decreased liver IR injury. Conclusion: These findings provide a novel mechanism by which IRF-1 regulates Rab27a transcription and EV secretion, leading to OxPL activation of neutrophils and subsequent hepatic IR injury. (HEPATOLOGY 2018;67:1056-1070). E xtracellular vesicles (EVs) are phospholipid bilayer particles that are generated by a conserved biological process. Secreted by most cell types and ubiquitously present in body fluids, EVs exert profound biological effects.
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(1-3) Their complicated effects result from their intricate composition of lipids, proteins, RNAs, and DNAs. (4) However, the regulatory mechanisms of EV secretion, especially under different pathophysiologic situations, remain largely unknown. Ischemia/reperfusion (IR) injury is a major clinical pathophysiologic concern in surgical resection, organ transplantation, myocardial infarction, and stroke. (5, 6) The effects of EVs during IR injury are mainly unknown.
We have shown that interferon regulatory factor 1 (IRF-1) is a transcription factor that plays an important role in hepatic IR injury. (7) IRF-1 has been shown to regulate guanosine triphosphatase (GTPase) expression (8) and secretion of melanosome, a type of EV. (9) Interestingly, many GTPases participate in vesicular trafficking and EV secretion. In particular, Rab27a, a small GTPase, is known to play an important role in Abbreviation: Ad, adenovirus; ALT, alanine aminotransferase; BMDN, bone marrow-derived neutrophil; CD, cluster of differentiation; ChIP, chromatin immunoprecipitation; EV, extracellular vesicle; GTP, guanosine triphosphate; GTPase, guanosine triphosphatase; hHC, human hepatocyte; hepEV, hepatocyte secreted EV; hypo-hepEV, hypoxic hepEV; IFNc, interferon c; IL, interleukin; IR, ischemia/reperfusion; IRF-1, interferon regulatory factor 1; KO, knockout; mHC, mouse hepatocyte; MVB, multiple vesicular body; norm-hepEV, normoxic hepEV; OLTx, orthotopic liver transplantation; OxPL, oxidized phospholipid; SCR, scramble; sEV, serum EV; shRNA, short hairpin RNA; TLR-4, toll like receptor 4; TNF-a, tumor necrosis factor a; WT, wild type.
EV secretion.
(10) Therefore, we hypothesize that IRF-1 may regulate EV secretion through Rab27a in hepatic IR.
We further sought to examine the mechanisms by which EVs regulated by IRF-1 and Rab27a affect IR injury. Oxidative stress is a major pathophysiologic mechanism during IR injury. Oxygen radicals generated during oxidative stress can cause phospholipid oxidation. Phospholipids, an integral component of cell membranes, are also present on EVs. Oxidized phospholipids (OxPLs) are found in dying cells (11) and IR-damaged tissues. (12) (13) (14) Of note, oxidized membranes of EVs are known to contain OxPLs. The surface OxPLs of EVs are secreted by parent cells undergoing oxidative stress and can activate toll-like receptor 4 (TLR-4). (15) There is evidence that TLR-4 ligands are increased during IR injury and that TLR-4 activation can promote IR injury. (16, 17) TLR-4 on neutrophils, a major immune cell population in IR injury, can be activated during IR. (18) We hypothesize that IRF-1-Rab27a regulated EVs can promote IR injury by activating neutrophils through EV OxPLs and the neutrophil TLR-4 pathway.
Materials and Methods

ETHICS
Human hepatocytes (hHCs) and mouse hepatocytes (mHCs) were isolated using protocols approved by the University of Pittsburgh institutional review board. loxP/-;Lyz-cre (Lyz-TLR4 KO) mice from a B6 background were provided by Dr. Timothy R. Billiar. All animals were housed or bred in the specific pathogen-free animal facility at the University of Pittsburgh School of Medicine and had access to food and water ad libitum.
CELLS AND REAGENTS
Huh-7 and Hep G2 human hepatoma cell lines and Hepa 1-6 mouse hepatoma cell line were purchased from American Type Culture Collection (Rockville, MD). Human IRF-1 expression plasmid and backbone plasmid were ordered from Origene (Rockville, MD). b-Galactosidase expression plasmid was purchased from Promega (Madison, WI). Mouse IRF-1 expression adenovirus (Ad-mIRF-1) and bgalactosidase expression adenovirus (Ad-LacZ), mouse Ad-Rab27a short hairpin RNA (shRNA), adenovirus scramble shRNA (Ad-SCR), and control adenovirus backbone, targeting both human and mouse Ad-IRF-1 shRNA, were ordered from Vector Biolabs (Malvern, PA). Antibodies against IRF-1 (SC-640; Santa Cruz), cluster of differentiation 63 (CD63; SC-15363, Santa Cruz), calnexin (SC-6465; Santa Cruz), CD81 (160523-006; System Biosciences), heat shock protein 70 (ab2728; Abcam), Rab27a (ab55667; Abcam), bactin (8H10D10; CST), and lamin A/C (4C11; CST) were used for western blot. TopFluor-labeled E06 antibody (Avanti Polar Lipids), which targets OxPLs, was used to detect OxPLs on EVs by flow cytometry.
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Results
Rab27a IS INDUCED DURING LIVER IR: Rab27a SILENCING DURING IR DECREASES LIVER DAMAGE AND SERUM EV CONCENTRATION
During warm IR in mice, hepatic Rab27a mRNA and protein were induced in a time-dependent manner (Supporting Fig. S1A; Fig. 1A, 1B) . As expected, liver damage peaked at 6 hours after warm IR (Fig. 1C) . Silencing of hepatic Rab27a expression with AdRab27a shRNA reduced liver injury as measured by serum alanine aminotransferase (ALT) levels, while Ad-SCR and control adenovirus backbone had no effect (Fig. 1C) . Likewise, hepatic necrosis after IR was significantly decreased by Rab27a silencing as shown by liver hematoxylin and eosin staining ( Fig.  1D; Supporting Fig. S1C ). Western blot for Rab27a confirmed silencing of Rab27a protein with decreased basal and IR-induced Rab27a expression in liver after Ad-Rab27a shRNA pretreatment for 48 hours (Supporting Fig. S2A,B) . To detect Rab27a activity, we used Slp homology domain glutathione S-transferase fusion protein to pull down GTP-conjugated Rab27a as an assay for Rab27a activity. The active form of Rab27a, GTP-conjugated Rab27a, was also increased during liver IR (Supporting Fig. S1D,E) . The GTPbound active form of Rab27a corresponds well with total Rab27a levels including Rab27a silencing or the IRF-1 KO group (data not shown) after different time points of reperfusion. These data confirm that Rab27a activity is increased during IR along with increased Rab27a transcription.
Next, we isolated serum EVs (sEVs) from shamtreated and IR-treated mice with an sEV isolation kit. The sEV concentration increased in a time-dependent manner 6-12 hours after warm IR, as quantified with a CD81 exosome enzyme-linked immunosorbent assay kit (Fig. 1E) , and corresponded to the Rab27a protein expression and its activity shown in Fig. 1A (see also Supporting Fig. S1D ,E). Silencing of Rab27a expression in vivo with Ad-Rab27a shRNA decreased sEVs 6-24 hours after IR (Fig. 1F ). Bigger sEV pellets were observed 6 hours after IR (Supporting Fig. S2C ), and sEVs were visually confirmed by transmission electron microscopy (Supporting Fig. S2D ). By western blot analysis, sEV lysates contained markers CD63, CD81, and heat shock protein 70 but not the endoplasmic reticulum marker calnexin (Supporting Fig. S2E ).
IRF-1 KO MICE HAVE DECREASED Rab27a INDUCTION, sEV SECRETION, AND LIVER DAMAGE AFTER IR
Hepatic IRF-1 expression was rapidly induced 2 hours after warm IR ( Fig 
HYPOXIA/REOXYGENATION PROMOTES mHC AND hHC EV SECRETION IN AN IRF-1/Rab27a-DEPENDENT MANNER
In order to confirm the relationships among IRF-1, Rab27a, and EV secretion, we isolated mHCs and hHCs and exposed them to hypoxia/reoxygenation to simulate IR injury. (19) Rab27a was markedly induced 6 hours after reoxygenation in both mHCs ( To examine the effects of hypoxia/ reoxygenation on EV secretion from cultured hepatocytes, supernatants were collected 24 hours after reoxygenation, and EVs were isolated by ultracentrifugation. Hypoxia/reoxygenation significantly induced EV secretion in mHCs (Fig. 3C ). This effect was abrogated when Rab27a was silenced with Ad-Rab27a shRNA infection (48-hour pretreatment) (Fig. 3C) .
Next, to determine the effect of IRF-1 on hepatocyte EV (hepEV) secretion, mHCs were isolated from IRF-1 KO mice. Unlike WT mHCs, these cells did not show increased EV secretion after reoxygenation (Fig. 3D ). Increased EV secretion was also observed in hHCs ( Fig. 3E ) during hypoxia/reoxygenation. Silencing of hHC IRF-1 with Ad-IRF-1 shRNA decreased Rab27a protein expression (Supporting Fig. S4A ,B) and EV secretion in response to hypoxia/reoxygenation (Fig. 3E ). EVs were examined and confirmed by transmission electron microscopy and western blot for EV markers (Supporting Fig. S4C,D) . These data can confirm that Rab27a induction during IR is not a result of immune cell infiltration.
INDUCTION OF IRF-1 BY INTERFERON c PROMOTES Rab27a TRANSCRIPTION, TRANSLATION, AND SUBSEQUENT EV SECRETION
To confirm the link between IRF-1 and Rab27a, we added interferon c (IFNc) to induce endogenous IRF-1 in primary hHCs and the human hepatoma cell line Huh-7. IFNc induced IRF-1 and Rab27a mRNA expression 6 hours after stimulation in a dose- dependent manner (Supporting Fig. S4A ). IRF-1 and Rab27a protein levels were also induced by IFNc in a dose-dependent manner 12 hours after stimulation (Fig. 4A,B) . Likewise, both IRF-1 and Rab27a mRNA and protein were induced by IFNc in the Huh-7 cell line ( Fig. 4C,D; Supporting Fig. S5B,C) . Consistent with the Rab27a induction, EV secretion was also increased in hHCs (Supporting Fig. S5D ) and Huh-7 cells (Supporting Fig. S5E ) after IFNc stimulation. Fluorescence microscopy also showed that IFNc increased IRF-1 and Rab27a expression after 12-hour treatment (Supporting Fig. S6 ). Because cytoplasmic multiple vesicular bodies (MVBs) store EVs before release, we examined the effect of IFNc by confocal microscopy on MVBs and showed that IFNc induced MVBs in hHCs and Huh-7 cells (Supporting Fig. S7A,B) .
OVEREXPRESSION OF IRF-1 INDUCES Rab27a EXPRESSION AND EV SECRETION
Next, to determine if IRF-1 overexpression (in the absence of exogenous IFNc) also increased Rab27a expression and EV secretion, the murine hepatoma cell line Hepa1-6 was infected with Ad-mIRF-1. IRF-1 protein expression was confirmed at 24-48 hours after Ad-mIRF1 infection (Fig. 4E,F) . This was associated with increased Rab27a protein expression (Fig. 4E,F 
IRF-1 PROMOTES Rab27a TRANSCRIPTION THROUGH DNA BINDING MOTIFS IN THE Rab27a PROMOTER REGION
As IRF-1 is a transcription factor, we hypothesized that IRF-1 could bind directly to the Rab27a promoter region and promote Rab27a transcription. The bioinformatics software PROMO was used to predict IRF-1 binding motifs. Ten possible motifs were found within a 1.6-kbp area of the human Rab27a promoter region (Supporting Fig. S8 ). We designed five PCR primers around this DNA region (Supporting Table S1 ) and performed a ChIP assay. IRF-1 antibody pulled down a protein-DNA complex from the ChIP primer 3 set (Fig. 5A) . Immune precipitation was not observed with the other primers (data not shown). Positive ChIP results were identified in the primer 3 region, which spans from -647 to -337 bp of the human Rab27a promoter and contains five IRF-1 binding motifs, as illustrated in Fig. 5B . We confirmed the binding ability of the five motifs with an electrophoretic mobility shift assay (Supporting Fig. S9 ). These findings indicate that IRF-1 binds to the Rab27a promoter region.
Next, luciferase assays were done using the -1.4-kbp Rab27a promoter reporter plasmid. Stimulation with IFNc for 6 hours increased Rab27a promoter activity in a dose-dependent manner (Fig. 5C ). Transfection efficiency was normalized to b-galactosidase. Cotransfection of IRF-1 expression plasmid also increased Rab27a promoter activity in a dose-dependent manner (Fig. 5C ). Hepatocyte-derived EVs were isolated by ultracentrifugation. After lysed with lysis buffer, EV protein concentrations were detected with the bicinchoninic acid method. n 5 6 for each group. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. Abbreviations: Ad-CTL, control adenovirus; NS, nonsignificant.
To verify that the active IRF-1 DNA binding motifs were in the primer 3 region spanning from -647 to -337 bp in the human Rab27a promoter, we generated Rab27a promoter deletional constructs using restriction endonucleases (Fig. 5D) . The full-length -1.4-kbp Rab27a promoter and the truncated -1.1-kbp Rab27a promoter showed significantly increased luciferase activity in response to IFNc stimulation or IRF-1 overexpression. In contrast, deletion of the five IRF-1 DNA motifs from -647 to -337 bp abrogated most of the promoter inducibility (Fig. 5E,F) . These data further confirm that IRF-1 binds the Rab27a promoter region in vivo.
EVs FROM HEPATIC IR OR HYPOXIC HEPATOCYTES CARRY HIGHER SURFACE OxPLs THAT ACTIVATE THE TLR-4 PATHWAY IN NEUTROPHILS
OxPLs increase during inflammation and IR injury (14) and promote inflammation. (20) We used the well-characterized E06 antibody to detect OxPLs on the surface of EVs attached to beads conjugated with anti-CD81 antibody with flow cytometry. (21) We found increased amounts of OxPLs on the surface of sEVs from IR mice compared to sham (Fig. 6A,B) , as well as increased amounts of OxPLs on hypoxic hepEVs (hypo-hepEV) in comparison to normoxic hepEVs (norm-hepEV) (Fig. 6C,D) . In contrast, the IRF-1 and Rab27a induction by IFNc did not increase the OxPLs on EVs (Supporting Fig. S10A,B) .
Because OxPLs are known to activate the TLR-4 pathway, we assessed the effect of EVs on the neutrophil TLR-4 pathway using WT and TLR-4 KO bone marrow-derived neutrophils (BMDNs). First, we showed by ImageStream that nuclear factor jB p65 was translocated to the cell nucleus when BMDNs were cocultured with hypo-hepEVs (Supporting Fig.  S11A ). In contrast, p65 remained in the cytoplasm when the TLR-4 KO BMDNs were cocultured with hypo-hepEVs (Supporting Fig. S11B ). To quantify the p65 nuclear translocation, a similarity score was generated where a higher score indicated greater nuclear translocation. Hypo-hepEVs cocultured with WT (but not TLR-4 KO) BMDNs had greater similarity scores compared to norm-hepEVs or phosphatebuffered saline (Supporting Fig. S11C-E) . Neutralization of the OxPLs with E06 antibody abrogated the p65 nuclear translocation (Supporting Fig. S11E ), which indicates that the BMDN nuclear factor jB nuclear translocation depends on EV OxPLs.
Next, we tested BMDN activation by measuring supernatant interleukin-6 (IL-6) from the cocultures. We observed that hypo-hepEVs promoted BMDN IL-6 production when cocultured with WT BMDNs but not when cocultured with TLR-4 KO BMDNs (Fig. 6E) , suggesting that BMDN activation is dependent on the TLR-4 pathway. Neutralization of the OxPLs from hypo-hepEVs with E06 antibody abrogated the increased IL-6 production (Fig. 6F) . Thus, the OxPLs from hypo-hepEVs activate BMDN Experiments were performed after 48 hours of IRF-1 expression plasmid cotransfection or IFNc 6-hour treatment. n 5 6 in each group. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. Abbreviations: CM, conditioned medium; CTL, control; bGal, b-galactosidase; IgG, immunoglobulin G; TSS, transcription starting site. nuclear factor jB nuclear translocation and IL-6 production in a TLR-4-dependent manner.
Hypo-hepEVs REVERSE THE PROTECTIVE EFFECT OF Rab27a SILENCING IN VIVO IN A TLR-4-DEPENDENT MANNER
To confirm that OxPLs cause liver damage during IR, we injected WT IR mice with E06 antibody at the time of reperfusion and found decreased IR damage as measured by ALT and necrotic area (Fig 7A;  Supporting Fig. S12A,D) . Next, to determine if hypo-hepEVs promote liver injury in the absence of IR injury, we injected WT mice with hypo-hepEVs and found no significant effect (data not shown).
Hypo-hepEVs could reverse the protective effect of Rab27a silencing during IR by in vivo delivery. The increased liver damage was mediated at least in part by OxPLs because the E06 antibody ameliorated the injury ( Fig. 7B; Supporting Fig. S12B,E) . Additionally, Lyz-TLR-4 KO mice, in which TLR-4 is knocked out specifically in myeloid cells (neutrophils, macrophages, etc.), were treated with hypo-hepEVs; there was no significant increase in liver damage after IR, suggesting that hypo-hepEVs signal through the TLR-4 pathway ( Fig. 7C; Supporting Fig. S12C,F) . Serum cytokine levels of IL-6 and tumor necrosis factor a (TNF-a) decreased by E06 antibody, further confirming that OxPLs promote liver damage (Fig.  7D) . Likewise, in the setting of Rab27a silencing in vivo, IL-6 and TNF-a concentrations in sera increased by injection of hypo-hepEVs and were and TNF-a after hypo-hepEV injection in Rab27a-silenced mice. (F) Liver Ly6G-positive neutrophil quantification and serum neutrophil elastase activity measurement 6 hours after reperfusion. n 5 6 in each group. *P < 0.05, **P < 0.01, ****P < 0.0001. Abbreviations: Ad-CTL, control adenovirus; HPF, high-power field (340); IgM, immunoglobulin M; NS, nonsignificant; PBS, phosphate-buffered saline; pNA, p-nitroanilide.
reversed by OxPL neutralization with E06 antibody (Fig. 7E) .
Because the in vitro data showed that IR-released EVs activate neutrophils through the TLR-4 pathway, we examined neutrophil infiltration and activation in vivo. Immunofluorescence staining showed that livers from IR-treated IRF-1 KO, Rab27a silencing, and Lyz-TLR-4 KO mice had less Ly6G-positive neutrophil infiltration after 6 hours of reperfusion (Supporting Fig. S13A; Fig. 7F ) compared to WT counterparts. Neutrophil elastase activity, a neutrophil activation marker, was also decreased in IRF-1 KO, Rab27a silencing, and Lyz-TLR-4 KO mice liver after 6 hours of reperfusion (Fig. 7F) . HypohepEVs could reverse the diminished neutrophil infiltration and elastase activity after Rab27a silencing compared with the norm-hepEV injection group. Furthermore, E06 antibody abrogated the effects (Supporting Fig. S13B; Fig. 7F) . Hence, the in vitro and in vivo data showed that IR-released EVs can 
Rab27a INDUCTION DURING LIVER TRANSPLANT IR IS MEDIATED IN PART BY IRF-1 SIGNALING
Expression of hepatic Rab27a has not been examined in the liver transplant setting. We performed murine B6 isograft OLTx after 20 hours of cold storage in UW solution and observed that hepatic Rab27a was induced in a time-dependent manner (Fig. 8A) . Because our data implicated IRF-1 in regulating Rab27a expression, we used IRF-1 KO mice as donors of liver isografts. We found that Rab27a induction after OLTx with IRF-1 KO donor grafts was markedly decreased in comparison to WT donor grafts (Fig.  8B ). Hepatic IRF-1 protein was induced in vivo in a time-dependent manner after OLTx (Fig. 8C) as before. (7) In comparison to WT grafts, IRF-1 KO grafts led to significantly decreased OLTx IR injury as measured by serum ALT (Fig. 8D ). To confirm a functional role for Rab27a in OLTx IR injury, we silenced the liver graft Rab27a with Ad-Rab27a shRNA intravenous injection and transplanted the grafts 48 hours later. ALT levels were significantly decreased in recipients of Ad-Rab27a shRNA-treated grafts in comparison to Ad-SCR (Fig. 8E) .
Next, we measured the effect of OLTx IR on sEV levels and found that sEVs doubled in WT mice 6 hours after OLTx (Fig. 8F) . IRF-1 KO isografts did not exhibit this increase in sEVs, suggesting that sEV secreting induction is IRF-1-dependent. Silencing Rab27a in the donor grafts abrogated the increase in sEV levels after OLTx (Fig. 8F) . Likewise, apoptosis measured by terminal deoxynucleotidyl transferase deoxyuridine triphosphate nick-end labeling staining was decreased after OLTx in IRF-1 KO or Rab27a-silenced liver grafts (Supporting Fig. S14C,D) . Serum IL-6 and TNF-a levels were consistent with these results (Supporting Fig. S14E,F) . Taken together, these data suggest that Rab27a plays an IRF-1-dependent role in OLTx IR injury.
Discussion
The major findings of this study are (1) hepatic IR injury in vivo or hypoxia/reoxygenation of hepatocytes in vitro induced Rab27a expression and subsequent EV secretion in an IRF-1-dependent manner, (2) Rab27a activity also increased during liver warm IR and correlated well with the increase of Rab27a transcription and translation, (3) IRF-1 induced Rab27a transcription by binding to five specific IRF-1 binding motifs in the Rab27a promoter, (4) IRF-1 KO or IRF-1 silencing decreased Rab27a expression and EV secretion, and (5) EV surface OxPLs generated during redox stress activate neutrophils in a TLR-4-dependent manner to exacerbate liver damage. Taken together, these findings demonstrate that oxidative stress during hepatic IR injury induces IRF-1 that regulates Rab27a transcription to control EV secretion. Secreted EVs contribute to hepatic IR through OxPL activation of the neutrophil TLR-4 pathway.
Based on the current literature, the term "EV" includes exosome, microvesicle, and apoptotic cellderived EVs, each with different biogenesis, size, and molecular composition. (22) Exosomes are small EVs that originate within the endocytic compartment of living cells. They are isolated from culture supernatants or bodily fluids by ultracentrifugation (100,000g). However, it has been shown that the population of small EVs includes vesicles of exosomal and nonexosomal origin. (23) Thus, to avoid confusion with the terminology of EV and to be consistent throughout the article, we have used the term "extracellular vesicle" for "EV" instead of "exosome."
There is an abundant literature showing that EVs play important roles in cell communication (24, 25) and can be used as biomarkers. (26) The mechanisms, by which cells regulate EV secretion, especially after physiological or pathological stress, remain largely unknown. IR injury is inevitable during organ transplantation, stroke, or myocardial infarction. IR (27) and hypoxia (28) have been shown to enhance EV secretion, but the mechanisms remain unknown. It has been demonstrated that Rab27a plays an important role in EV secretion (10) ; however, the regulators of Rab27a-mediated EV secretion are unknown. This study shows that IRF-1 regulates Rab27a-mediated EV secretion during IR injury. Although we found that IFNctreated Huh-7 cells increased their content of MVBs, the ultimate mechanisms by which the IRF-1-Rab27a axis increases generation and secretion of EVs will require more detailed analysis in future studies.
Transcriptional regulation allows cells to respond to a variety of intracellular and extracellular stresses. Previously, we showed that hepatic IR activates the transcription factor IRF-1.
(7) Here, we demonstrate that IRF-1 induces Rab27a transcription and translation, which promotes EV secretion. We also showed that the activity of Rab27a (determined by the concentration of the GTP-bound active form of Rab27a) correlated well with total Rab27a levels. These data are consistent with the notion that the main regulation of Rab27a is at the transcriptional level during IR.
IRF-1, as well as other IRF family members, promotes transcription of target genes by binding the IRF element or IFN-stimulating response element in target gene promoter regions. (29) IFN-stimulating response elements in the Rab27a promoter region were first predicted by bioinformatics and then confirmed by ChIP and electrophoretic mobility shift assay. Similar to our findings that IRF-1 regulates EV secretion, others have shown that IRF-1 regulates the secretion of melanosomes, another type of EV. (9) Furthermore, IRF family members regulate the expression of other GTPases, (30) (31) (32) which play important roles in cellular vesicle transport. (33) Our research demonstrates the important role of the IFN pathway and IRF family members in the release of EVs.
Our data show that EV secretion is increased in both warm and cold liver IR. Silencing of Rab27a led to decrease EV secretion and subsequent alleviation of liver damage. Though it has been demonstrated that adenovirus concentrates mainly in the liver after intravenous injection, we cannot rule out the effects of extrahepatic Rab27a silencing, particularly in neutrophils, where Rab27a is known to be active. (34) Western blot showed that Rab27a expression is not significantly changed in platelets or kidney tissue. There was minimal decrease in lung tissue. This further confirms that the protective effects of AdRab27a shRNA during liver IR come from the liver Rab27a silencing. It also means that the protective effect should come from the inhibition of liver EV secretion. In addition, our liver transplant experiments with Rab27a silencing in the liver grafts resulted in decreased sEV concentration and post-OLTx IR injury, which confirms the importance of the hepatic Rab27a-EV pathway during transplantation-related IR because the recipients were Ad-Rab27a shRNAfree. Though the mechanisms of cold and warm IR are not identical, these data further confirm that inhibiting liver EV secretion through Rab27a silencing has a protective effect in IR injury.
A myriad of components mediate the effects of EVs. There is limited evidence that EVs secreted by hepatocytes promote liver repair and regeneration after IR. (27) In our study, we found that EVs secreted after hepatic IR promote damage through surface OxPLs.
IR injury, a form of oxidative stress, results in formation of oxygen radical species. These free radicals can oxidize unsaturated fatty acids in phospholipids and generate OxPLs. (35) OxPLs are found not only in IRrelated diseases (14, 35) but also in dying cells and acute lung injury. (20) In vitro studies have demonstrated that EVs contain surface OxPLs. (15, 36) Our in vivo study shows that inflamed tissue releases OxPLs through EVs. Accordingly, treatment of mice with the E06 antibody, which blocks the effects of OxPLs, decreased IR damage and blocked neutrophil activation by hypohepEVs.
TLR-4 ligands play a pivotal role in IR injury. (37) Our data show that EVs express membrane OxPLs and act as TLR-4 ligands. In particular, phospholipids are major components of eukaryotic biomembranes. (38) Oxidized 1-palmitoyl-2-(5-oxovaleroyl)-snglycero-3-phosphorylcholine, one type of OxPL, has been found on EVs. (36) Oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine, another OxPL, has been shown to exacerbate acute lung injury through a TLR-4 pathway. (20) In concordance with our work, another in vitro study found that EVs secreted during oxidative stress contain OxPLs, which can activate the TLR-4 pathway. (15) EVs isolated from body fluids are also able to activate immune cells through the TLR-4 pathway. (39) The specific role of OxPLs in the TLR-4 pathway remains controversial. Some studies show that OxPLs can activate the TLR-4 pathway, (20) while others refute that finding (40) or suggest that OxPLs inhibit lipopolysaccharide-mediated TLR-4 activation. (41) Our data clearly show that OxPLs activate neutrophil TLR-4. We propose that TLR-4 activation is dependent on the cell type and that TLR-4 activation by OxPLs is less efficacious than by lipopolysaccharide, a theory verified by Oskolkova et al. (42) This may explain why hypo-hepEVs, unlike lipopolysaccharide, could not significantly cause naive mice liver damage. Because other cells such as macrophages and hepatocytes also express TLR-4, we cannot rule out TLR-4 activation by OxPL-positive EVs on other cell types. In any case, our work confirms that IR-induced EVs promote liver damage and that blockade of this mechanism may have potential as a therapeutic target.
In conclusion, our research shows that EVs induced by liver IR are regulated by the IRF-1-Rab27a axis and that the EVs promote IR injury through the neutrophil TLR-4 pathway. Rab27a-generated and IR-generated EVs represent targets to ameliorate liver damage during hepatic IR injury and other IR-related diseases.
